Restricted use for spinal tumour treatment:
This article was originally published in Clinica
Executive Summary
Interpore Cross International has received permission from the US FDA to sell a limited number of its expandable titanium spacers for replacing spinal segments under a humanitarian device exemption (HDE). The Telescopic Plate Spacer can be used where patients have had one of two spine vertebral bodies removed due to cancer. The Irvine, California-based company said the device is designed to allow insertion of bone graft material, adding that there are no other FDA-cleared devices that function in the same way. An HDE allows companies to market products for treating conditions that affect fewer than 4,000 people.
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.